Dr. Negrin University Hospital
Las Palmas de Gran Canaria, Las Palmas, 35019, Spain
NCT Number: NCT03282695
The main objective of this study is to estimate the cost-effectiveness of ozone therapy in patients on the waiting list for surgery due to disc herniation.
This study is active but is not currently recruiting participants.
Notify Me18 year–75 year
All sexes
Observational
Las Palmas de Gran Canaria, Las Palmas, 35019, Spain
A cohort study (patients on the waiting list for surgery due to herniated disc) will be carried out, to which the treatment with ozone will be offered, without giving up the planned surgical intervention.
The main objective of this prospective, post-authorization follow-up study is to estimate the cost-effectiveness of ozone therapy (compared to standard care) in patients with disc herniation waiting for surgery (by microdiscectomy). Besides utilities of patients with disc herniation on a waiting list for surgery will be estimated, social/economic burden of disc herniation will be quantified and a decision aid will be developed and applied.
The main outcome measures are "Direct hospital cost", "Percentage of executed surgeries" and "Change in sciatic pain". In addition, data on health-related quality of life and resource utilization will be collected which will permit to estimate the incremental cost-effectiveness ratio (ICER), comparing incremental costs and quality adjusted life years (QALY).
The variables will be collected at the beginning, on the day of treatment and at 1, 3, 6, 12 and 24 months. The enrollment period will be 24 months. The follow-up period will be 24 months.
The results of the study will allow a better understanding of the value of ozone therapy in the management of patients on the waiting list for herniated disc surgery. In addition, it will contribute to the development of a more patient-centered health system.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 24 months
Euros
Time frame: 24 months
Percentage of surgeries performed after enrollment
Time frame: 12 months
Visual Analogic Scale (VAS)
Time frame: 24 months
Visual Analogic Scale (VAS)
Time frame: 6 months
Visual Analogic Scale (VAS)
Time frame: 6 months
Visual Analogic Scale (VAS)
Time frame: 12 months
Visual Analogic Scale (VAS)
Time frame: 24 months
Visual Analogic Scale (VAS)
Time frame: 24 months
Number of hospital stay days
Time frame: 24 months
Spanish version of Roland-Morris questionnaire
Time frame: 24 months
SF-12 questionnaire
Time frame: 24 months
EQ-5D-5L questionnaire
Time frame: 24 months
Off work days (if applicable)
Time frame: 24 months
Days
Time frame: 24 months
Euros
Time frame: 24 months
Number of serious adverse effects
Time frame: 24 months
Days
Bernardino Clavo, MD, PhD
Other
Acronym: O3HDCIRUGIA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06525896
Back Pain, Bone Diseases
Stanford, California, United States
View Trial DetailsNCT07509580
Bone Diseases, Hernia
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03398915
Bone Diseases, Bone Diseases, Infectious
Innsbruck, Austria
View Trial DetailsNCT06369233
Bone Diseases, Hernia
Seongnam-si, South Korea
View Trial Details